These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34082692)

  • 1. Multidimensional study of cell division cycle-associated proteins with prognostic value in gastric carcinoma.
    Lu P; Cheng W; Fang K; Yu B
    Bosn J Basic Med Sci; 2022 Feb; 22(1):64-76. PubMed ID: 34082692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 3. CDCA gene family promotes progression and prognosis in lung adenocarcinoma.
    Liu X; Zhu X; Zhao Y; Shan Y; Gao Z; Yuan K
    Medicine (Baltimore); 2024 Jun; 103(24):e38581. PubMed ID: 38875380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
    Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
    BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
    Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
    Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
    Zhao C; Zhou J; Xing J; Yin Q
    Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer.
    Li Z; Liu Z; Li C; Liu Q; Tan B; Liu Y; Zhang Y; Li Y
    Transl Cancer Res; 2021 Jul; 10(7):3404-3417. PubMed ID: 35116645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
    Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Medicine (Baltimore); 2022 Feb; 101(5):e28788. PubMed ID: 35119046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
    Wu ZH; Fang M; Zhou Y
    PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulators CDCA8 as potential targets and biomarkers for the prognosis of human skin cutaneous melanoma.
    Guo R; Ying J; Jia L; Zhuang N; Jiang H; Xiong J
    J Cosmet Dermatol; 2022 Nov; 21(11):6034-6048. PubMed ID: 35575979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
    Guo Y; Wang ZW; Su WH; Chen J; Wang YL
    Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Expression of
    Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
    Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
    Xue D; Li D; Dou C; Li J
    Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
    Du Y; Wang Z; Wan W
    J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
    [No Abstract]   [Full Text] [Related]  

  • 19. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
    Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of centromere protein N as novel biomarkers for gastric adenocarcinoma.
    Wang X; Zhang K; Fu C; Wu F; Zhang J; Han B; Pan H; Luan L
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1798. PubMed ID: 36916294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.